Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Cantor Fitzgerald
QuintilesIMS
Healthtrust
US Army
Novartis
Citi
Mallinckrodt
Queensland Health

Generated: October 17, 2017

DrugPatentWatch Database Preview

Drug Master Files for: pregabalin

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
22111AII10/23/2008MSN PHARMACHEM PRIVATE LTDPREGABALIN [ROUTE CODE - PB]
22128AII11/27/2008SUN PHARMACEUTICAL INDUSTRIES LTDPREGABALIN
22165AII11/10/2008MYLAN LABORATORIES LTD(S)-PREGABALIN
22223AII11/24/2008CHANGZHOU PHARMACEUTICAL FACTORYPREGABALIN
22242AII12/1/2008TEVA PHARMACEUTICAL INDUSTRIES LTDPREGABALIN DRUG SUBSTANCE
22330AII12/17/2008LUPIN LTDPREGABALIN
22485AII2/3/2009MYLAN LABORATORIES LTDPREGABALIN
22925AII7/8/2009CADILA HEALTHCARE LTDPREGABALIN
23342III11/30/2009ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTDPREGABALIN
24196AII9/21/2010OLON SPAPREGABALIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Farmers Insurance
Merck
Boehringer Ingelheim
Fish and Richardson
Chubb
Covington
Queensland Health
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot